immunosuppression

Documents about immunosuppression

• (TNX-1500) in Kidney Transplant Recipients#904531ClinicalTrials.gov
• Once Daily Immunosuppression Regimen#869818ClinicalTrials.gov
• Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients#903586ClinicalTrials.gov
• TRU-IMMUNO: Optimizing Liver Immunosuppression#866295ClinicalTrials.gov
• Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)#862347ClinicalTrials.gov
• Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression#909534ClinicalTrials.gov
• Immunosuppression Optimization Using The Prospera Assay In Kidney Transplant Recipients (IMPAKT)#878653ClinicalTrials.gov
• Use of DNA Testing and Gene Expression Profiling to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression#839953ClinicalTrials.gov
• Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation#160215ClinicalTrials.gov
• Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test#867467ClinicalTrials.gov
• Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients#993726ClinicalTrials.gov
• Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status#802751ClinicalTrials.gov
• Minimizing Immunosuppression in Old for Old Kidney Transplantation#849833ClinicalTrials.gov
• Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients#853225ClinicalTrials.gov
• The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient#893726ClinicalTrials.gov
• Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)#992260ClinicalTrials.gov
• Torque Teno Virus: A Biomarker of Immunosuppression#864452ClinicalTrials.gov
• Blood-Bile Ratio Tacrolimus After Liver Transplantation#898908ClinicalTrials.gov
• Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation#842141ClinicalTrials.gov
• Plasma Levels of Danger-Associated Molecular Patterns in Young Children After Cardiac Surgery Under Cardiopulmonary Bypass#908987ClinicalTrials.gov
• Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.#874547ClinicalTrials.gov
• Tolerance Through Mixed Chimerism (Sip-Tego)#968605ClinicalTrials.gov
• Influenza Vaccination in Immunocompromized Patients#435803ClinicalTrials.gov
• Protective Immunity Project 01#804425ClinicalTrials.gov
• Immunosuppression and COVID-19 Boosters#846697ClinicalTrials.gov
• Vaccination in systemic lupus erythematosus#205415Europe PMC
• Comparative Analysis of Anti-COVID-19 (Severe Acute Respiratory Syndrome) Humoral and Memory T Cell Responses in Children With Various Degrees of Immunosuppression:#802286ClinicalTrials.gov
• Immunosuppression and Intensive Care Unit-acquired Multidrug-resistant Bacteria#398344ClinicalTrials.gov
• Envarsus XL Immunosuppression Following Liver Transplantation#901499ClinicalTrials.gov
• Belatacept in Liver Transplant Recipients#910455ClinicalTrials.gov
• Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid#803613ClinicalTrials.gov
• PREPARE-iVAC Trial#454081ClinicalTrials.gov
• Macrophage PABPC4-SPP1 Axis Orchestrates Immunosuppression in Colorectal Cancer.#479344NCBI PubMed Central
• Epidemiology of Diverticulitis in Lung Transplant Recipients#833643ClinicalTrials.gov
• Hyper-inflammation and immunosuppression: redefining sepsis therapy using modern approaches.#334755NCBI PubMed Central
• Weaning of Immunosuppression in Nephritis of Lupus#847639ClinicalTrials.gov
• Monitoring of Septic Shock-induced Immunosuppression#849413ClinicalTrials.gov
• Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes#889812ClinicalTrials.gov
• Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression#127632ClinicalTrials.gov
• Histamine Dihydrochloride and Interleukin-2 in Primary Resectable Pancreatic Cancer#162470ClinicalTrials.gov
• LILRB3 inhibition reverses immunosuppression in glioma: a nanoparticle-based therapeutic strategy.#227878NCBI PubMed Central
• Increased immunosuppression and susceptibility to listeriosis in the aging population, France#274111HAL (France)
• The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients#424254ClinicalTrials.gov
• Microbial Invasion and Immunosuppression Drives Adenoma Progression in Early Colorectal Cancer Development#444933bioRxiv / medRxiv
• Islet Allotransplantation With Steroid Free Immunosuppression#876026ClinicalTrials.gov
• Expression and the Clinical Significance of Neutrophil PD-L1 During Sepsis#993312ClinicalTrials.gov
• Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer.#983NCBI PubMed Central
• Cortisol-resistant CAR-NK cells overcome steroid-induced immunosuppression in lung cancer#5442Europe PMC
• Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs#154854ClinicalTrials.gov
• RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients#373660ClinicalTrials.gov

Related topics